The Wall Street Analyzer | New York, NY

Latest News

[ January 14, 2025 ] HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma News Feed
[ January 8, 2025 ] Midnight Sun Completes Exploration Program at Kazhiba News Feed
[ December 30, 2024 ] Greenlite Ventures Expands Footprint to Four Blockchains Powered by NoLimitCoin Consumer
[ December 20, 2024 ] MobiCard’s Digital Business Card Revolutionizes Networking & Social Media News Feed
[ December 20, 2024 ] Sequoia Capital and the evolution of the VC industry | FT Film Consumer
[ December 16, 2024 ] Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryteTM for the Treatment of Cutaneous T-Cell Lymphoma News Feed
[ December 2, 2024 ] HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment Market News

SeaStar Medical Holding Corp (NASDAQ: ICU)

October 5, 2023 Comments Off on SeaStar Medical Holding Corp (NASDAQ: ICU)
Pro-Dex, Inc (NASDAQ: PDEX)

October 24, 2022 Comments Off on Pro-Dex, Inc (NASDAQ: PDEX)
Ocuphire Pharma, Inc. (Nasdaq: OCUP)

March 26, 2021 Comments Off on Ocuphire Pharma, Inc. (Nasdaq: OCUP)
Citius Pharmaceuticals (NASDAQ: CTXR) CEO Interview Update

January 28, 2020 Comments Off on Citius Pharmaceuticals (NASDAQ: CTXR) CEO Interview Update
Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

August 12, 2019 Comments Off on Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com